四个IPO，流血1375亿

Core Viewpoint - The investment landscape in 2023 is characterized by confusion, while 2024 is expected to be turbulent, leading to a more optimistic outlook for 2025, with the A-share market stabilizing into a "slow bull" phase and significant IPOs providing liquidity to the market [6][7]. Group 1: IPO Performance - In 2025, approximately 16% of IPOs experienced valuation discounts compared to their last financing round, marking the highest level in a decade [7]. - The second quarter of 2025 was particularly severe, with all IPOs over $1 billion completing with "market value inversion" [7]. - Four major IPOs in Q2 2025 collectively saw a market value reduction of $19.2 billion (approximately 137.5 billion RMB) [9]. Group 2: Notable IPOs - MNTN, an advertising company, went public in May 2025 with a target valuation of $1.1 billion, down from a previous valuation of $2 billion [9][10]. - Hinge Health, a digital healthcare service, had a market cap of $3 billion at IPO, down from $6.2 billion [10]. - Circle, a blockchain unicorn, completed its IPO in June 2025 with a valuation of slightly over $7 billion, down from a peak of $9 billion [10]. - Chime, a digital bank, went public with a valuation of $11.6 billion, significantly lower than its last funding round valuation of $25 billion, resulting in a market value drop of nearly $13.4 billion (approximately 96 billion RMB) [10][11]. Group 3: Market Context and Future Outlook - The total exit scale for the venture capital industry in 2025 was $67 billion, indicating a 29% reduction in expected assets for limited partners (LPs) [11]. - The term "bloody IPO" refers to the situation where companies go public at a lower valuation than anticipated, reflecting the market's cautious sentiment [11]. - Despite the challenges, companies like MNTN and Hinge Health are positioned as leaders in their respective fields, with MNTN's revenue growing tenfold since 2020 and Hinge Health showing significant improvement in financial performance [13][14].